The American Competes Reauthorization Act of 2015 was passed by a split House of Representatives Wednesday, amid opposition from a wide swath of the scientific community. The passage also came after hours of negotiations of the bill, which Republicans have said would keep overall federal spending flat – while opponents have said would constrain how the National Science Foundation would be able to spend that money.
Discussion targets changing financial environment for biomedical research.
President Barack Obama's nominee to serve as U.S. drug "czar" won unanimous approval in the...
New rules this week are bringing changes to the nation's kidney transplant system that will give some patients a better shot at a longer-lasting organ, and move others up the waiting list.
In a study that could provide the foundation for scientists to more precisely replicate natural stem cell development in an artificial environment, researchers have established a standard to assess how conditions used to procure stem cells in the lab compare to those found in a human embryo.
Striving to shine a light on potential ethical conflicts in medicine, the Obama administration is releasing data on drug company payments to tens of thousands of individual doctors.
More than 700 infants may have been exposed to tuberculosis at an El Paso hospital over the past year by an employee recently diagnosed with the illness, health officials said Friday.
The Food and Drug Administration on Friday revised sweeping food safety rules proposed last year after farmers complained that the regulations could hurt business.
Signaling the seriousness of the threat posed by antibiotic-resistant germs, President Barack Obama on Thursday ordered the government to create a national plan to fight them by early 2015.
The National Institutes of Health said it has uncovered a nearly century-old container of ricin and a handful of other forgotten samples of dangerous pathogens as it combs its laboratories for improperly stored hazardous materials.
The American Heart Association's first policy statement on electronic cigarettes backs them as a last resort to help smokers quit. The American Cancer Society has no formal policy but quietly took a similar stance in May.
The federal government is finalizing new restrictions on hundreds of medicines containing hydrocodone, the highly addictive painkiller that has grown into the most widely prescribed drug in the U.S.
An investigation into a potentially dangerous blunder at a government lab found that a scientist kept silent about the accident and revealed it only after other employees noticed something fishy.
The World Health Organization on Friday declared the Ebola outbreak in West Africa to be an international public health emergency that requires an extraordinary response to stop its spread. The WHO announced the Ebola outbreak — the largest and longest in history — is worrying enough to merit being declared an international health emergency. WHO declared similar emergencies for the swine flu pandemic in 2009 and for polio in May.
Thinking about getting inked? Check the bottle first. The Food and Drug Administration is warning tattoo parlors, their customers and those buying at-home tattoo kits that not all tattoo ink is safe.
The Food and Drug Administration says it will begin regulating laboratory-developed tests, a growing class of medical diagnostics that have never before been subject to federal oversight.
The European Society for Medical Oncology (ESMO) has expressed concern that the proposed EU General Data Protection Regulation could make cancer research impossible and add a significant burden to both doctors and cancer patients.
Health officials say that the head of the government lab which potentially exposed workers to live anthrax has resigned. Michael Farrell was head of the Centers for Disease Control and Prevention lab since 2009.
The same federal scientist who recently found forgotten samples of smallpox at a federal lab also uncovered over 300 additional vials, many bearing the names of highly contagious viruses and bacteria.
The government is expanding its "mystery disease" program, funding a network at six universities around the country to help diagnose patients with diseases so rare they've been told they're undiagnosable. The National Institutes of Health has evaluated hundreds of these cold-case patients in its campus research hospital as part of a pilot program since 2008. Demand is so great, there's a waiting list.
Food companies and restaurants could soon face government pressure to make their foods less salty — a long-awaited federal effort to try to prevent thousands of deaths each year from heart disease and stroke. The Food and Drug Administration is preparing to issue voluntary guidelines asking the food industry to lower sodium levels.
Ten projects that will enable non-government researchers to conduct clinical research at the National Institutes of Health’s Clinical Center in Bethesda, Md. were announced. Through these three-year, renewable awards of up to $500,000 per year, scientists from institutions across the United States will collaborate with government scientists in a highly specialized hospital setting.
In December 2013, the U.S. Food and Drug Administration approved the first high-throughput DNA sequencer. Helping get the new device approved was another first: the initial use of a reference set of standard genotypes, or "coded blueprints" of a person's genetic traits.
Getting in the right shape might be just as important in a biology lab as a gym. Shape is thought to play an important role in the effectiveness of cells grown to repair or replace damaged tissue in the body. To help design new structures that enable cells to "shape up," researchers at the NIST have come up with a way to measure, and more importantly, classify, the shapes cells tend to take in different environments.
The United States' predominance in science and technology eroded further during the last decade, as several Asian nations—particularly China and South Korea—increased their innovation capacities. According to a report released by the National Science Board, the major Asian economies, taken together, now perform a larger share of global R&D than the U.S.
Broader global access to lifesaving antiretroviral therapies and wider implementation of proven HIV prevention strategies could potentially control and perhaps end the HIV/AIDS pandemic. However, a safe and at least moderately effective HIV vaccine is needed to reach this goal more expeditiously and in a more sustainable way, according to a new commentary from Anthony S. Fauci, MD, director of the NIAID.
The National Institutes of Health, 10 biopharmaceutical companies and several nonprofit organizations today launched an unprecedented partnership to transform the current model for identifying and validating the most promising biological targets of disease for new diagnostics and drug development.
Researchers at the National Institute of Standards and Technology (NIST) and in Lithuania have used a NIST-developed laboratory model of a simplified cell membrane to accurately detect and measure a protein associated with a serious gynecological disease, bacterial vaginosis (BV), at extraordinarily low concentrations.
- Page 1